Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
about
A secreted tyrosine kinase acts in the extracellular environmentCellular mediators of renal vascular dysfunction in hypertensionAnti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plantsThe Discovery of Novel Genomic, Transcriptomic, and Proteomic Biomarkers in Cardiovascular and Peripheral Vascular Disease: The State of the ArtAssociation of Matrix Metalloproteinase-9 Gene -1562C/T Polymorphism with Essential Hypertension: A Systematic Review and Meta-Analysis ArticlePolypoidal Choroidal Vasculopathy in AsiansThe evolution of endothelial regulatory paradigms in cancer biology and vascular repairAcknowledged signatures of matrix metalloproteinases in Takayasu's arteritisWhy are sex and gender important to basic physiology and translational and individualized medicine?Using proteomics to uncover extracellular matrix interactions during cardiac remodeling.Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunctionZinc-chelation contributes to the anti-angiogenic effect of ellagic acid on inhibiting MMP-2 activity, cell migration and tube formationMatrix metalloproteinase-3 accelerates wound healing following dental pulp injuryProlonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cavaInvolvement of calcium-sensing receptor in oxLDL-induced MMP-2 production in vascular smooth muscle cells via PI3K/Akt pathwayMMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptidesInterstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1The postthrombotic syndrome: current evidence and future challenges.The role of extracellular signal-related kinase during abdominal aortic aneurysm formationCardiac fibroblast: the renaissance cell.Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.Doxycycline-mediated inhibition of choroidal neovascularization.Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a "Western-style diet" by increasing PPAR α and γ expression and reducing TC, MMP-9, and Cat S levels.RETRACTED: Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection.Integrins as "functional hubs" in the regulation of pathological angiogenesisGenome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue.Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failureAltered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.Extracellular matrix molecules: potential targets in pharmacotherapy.Substrate-dependent gene regulation of self-assembled human MSC spheroids on chitosan membranes.Thoracic aortic dissection: are matrix metalloproteinases involved?Regulation and involvement of matrix metalloproteinases in vascular diseasesEstrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vesselsPotential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function.Differential effect of wall tension on matrix metalloproteinase promoter activation in the thoracic aorta.Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats.
P2860
Q24303065-74151A07-D618-4F11-82D0-5C0EBDBC32BEQ24644250-0F5E45C9-6B36-4CBB-9A53-0BE7DF718465Q24649987-89CE6D29-EF7D-48D0-A9A8-0593B2B77967Q26746121-F65BB2A1-0667-4BB5-A866-C50657304A4FQ26770159-607BEB2E-212A-49B8-9A03-13FBD71ED153Q26799548-6E73FEAE-07B1-4F6A-A84C-1E2389934712Q26822678-8497FAF3-7E49-467F-B5FF-16E9F1D7C0DCQ26850781-09E025C0-5B40-4A0A-BE37-17CE1CDB8B36Q27022386-8AB7D8DC-2CE8-44BA-AA7A-1B6662D565C9Q27691351-4701F98A-0AC8-4683-98B6-2E2BD247AB22Q28236758-0AA043BB-2316-4626-ABB9-782068B8594CQ28478040-BCC5E507-7F00-4C0C-BC9E-45E983486F69Q28575871-9F70836D-DA44-486A-956A-D52A063CE0ABQ28576001-90A110B1-9EA4-4316-9CB6-8DF52B8A5CD8Q28581841-B928DBE6-8762-4768-BFA5-49170EEAAFD8Q28584210-96FC6027-EEA6-4A32-9D28-DBEE3A725EBEQ29347013-5B15C9FC-E185-4FD4-BC4A-612DB825FB7FQ30241064-35786383-96CE-4A2E-893C-F4583A52879DQ30416591-697E9189-9A27-49B1-981E-4E614495563EQ30467800-29CEFBC8-9B9F-4A94-B150-889C801EDF10Q30646015-BD389F82-33FD-4F1C-A109-3585A5E1D395Q33465433-ABA2A6F6-5DD2-4A54-8C37-0AD69AA408F3Q33577634-15AFC013-7AD9-484C-AC93-47D8C9250BD8Q33583711-E0751185-EE7B-4C6C-B145-6B9E902D4C40Q33591910-061E6E93-84ED-41C5-AF33-38AAC6FE1AE8Q33638451-30C94367-F6AD-4F21-9FCE-CBFBDC6E88BFQ33646549-54D18C36-98D4-4F98-915F-B3816B816375Q33654315-ACE7BA09-6AF1-4AB9-B6F9-254D80EC3F55Q33655952-AD607C22-3AC8-4ECA-8404-DB7F8380E545Q33665037-38FC5513-D441-46E4-B5C6-F7E6C68029A9Q33694487-7805ABA5-819F-40DB-9F7A-739D3DB1B520Q33715549-F566C912-40C2-4988-A9E6-3F4298D00183Q33745506-9DF13CDB-3273-4208-A9C3-27E538D6257DQ33773304-1D639993-1657-4E6C-A6A3-D42970D5C3A2Q33781367-5DFD06DA-7FF4-4507-BBB7-1BAE90746B37Q33786755-C2FB6B91-6B8F-4D12-9542-E9165FC7050DQ33797629-C23B065A-8B89-4F3A-80B1-CD8E2767F5D9Q33808299-E31079CD-726E-43EA-B636-771C23ADD0A0Q33872836-450ACB9F-C071-41BB-ACA0-FC0165F1D122Q33892142-D0CEDB8B-E166-490A-BB61-D1059ED2913C
P2860
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Matrix metalloproteinases and ...... emodeling and vascular disease
@ast
Matrix metalloproteinases and ...... emodeling and vascular disease
@en
type
label
Matrix metalloproteinases and ...... emodeling and vascular disease
@ast
Matrix metalloproteinases and ...... emodeling and vascular disease
@en
prefLabel
Matrix metalloproteinases and ...... emodeling and vascular disease
@ast
Matrix metalloproteinases and ...... emodeling and vascular disease
@en
P2860
P1476
Matrix metalloproteinases and ...... emodeling and vascular disease
@en
P2093
Joseph D Raffetto
Raouf A Khalil
P2860
P304
P356
10.1016/J.BCP.2007.07.004
P407
P577
2007-07-07T00:00:00Z